Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 139.0B | 175.5B | 134.7B | 132.2B |
Cost of revenue | 115.2B | 140.8B | 115.2B | 103.4B |
Gross profit | 23.8B | 34.7B | 19.5B | 28.9B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 3.2B | 3.7B | 3.3B | 2.9B |
Other operating expenses | 9.9B | 10.6B | 9.3B | 8.7B |
Operating income | 13.5B | 15.0B | 10.7B | 10.8B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 2.5B | 2.3B | 2.4B | 2.3B |
Other income expense | — | — | — | — |
Pretax income | 12.2B | 14.0B | 9.5B | 9.7B |
Tax provision | 3.5B | 3.5B | 2.4B | 2.6B |
Net income | 8.7B | 10.5B | 7.0B | 7.2B |
Basic EPS | — | 11.8 | 7.9 | 8.1 |
Diluted EPS | — | 11.8 | 7.9 | 8.1 |
Basic average shares | — | 887.3M | 886.6M | 887.1M |
Diluted average shares | — | 887.3M | 887.8M | 887.1M |
EBITDA | 16.5B | 18.0B | 13.6B | 13.7B |
Net income from continuing op. | — | — | — | — |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |